http://www.inboxrobot.com/news/bristol-squibbConstantly updated news and information about a variety of topics. http://www.inboxrobot.com/news.php?fid=191853632 7 Oct 2008 09:30 GMT ... topped two previous offers from Bristol- Myers Squibb Co., which partnered with ImClone to develop ... blockbuster drug Erbitux. In July, New York-based Bristol offered $60 per share for the 83 ... http://www.inboxrobot.com/news.php?fid=191851890 7 Oct 2008 09:02 GMT ... Both company boards have approved of the deal, which trumps a previous offer from Bristol-Myers Squibb, which offered ImClone $62 a share for the company, the Indianapolis Star reported. ... http://www.inboxrobot.com/news.php?fid=191846931 7 Oct 2008 07:30 GMT ... Eli Lilly and Co for about US$6.1bil after rebuffing a sweetened takeover offer from Bristol-Myers Squibb, sources familiar with the situation said yesterday. The agreement, which values ImClone at US$70 ... http://www.inboxrobot.com/news.php?fid=191845978 7 Oct 2008 07:24 GMT ... the company it does not already own. Bristol subsequently raised its offer last month by ... was in the best interest of Bristol-Myers Squibb shareholders not to raise our previous $62 ... http://www.inboxrobot.com/news.php?fid=191843143 7 Oct 2008 06:54 GMT ... by Carl Icahn, for $6.5bn or $70 per share, trumping a hostile bid from Bristol-Myers Squibb. BMS said yesterday it would drop its unsolicited offer at $62 per share and ... http://www.inboxrobot.com/news.php?fid=191841422 7 Oct 2008 06:32 GMT ... USD 6.1 billion. ImClone had previously rejected as too low two takeover offers from Bristol-Myers Squibb co, its marketing partner for the cancer drug Erbitux. Bristol-Myers made bids of USD ... http://www.inboxrobot.com/news.php?fid=191838595 7 Oct 2008 06:11 GMT ... bid topped two previous offers from Bristol-Myers Squibb Co., which joined with ImClone to develop ... blockbuster drug Erbitux. In July, New York-based Bristol offered $60 per share for the 83 ... http://www.inboxrobot.com/news.php?fid=191833518 7 Oct 2008 05:32 GMT ... New York-based ImClone had previously rejected as too low two lower-priced takeover offers from Bristol-Myers Squibb Co., its marketing partner for the cancer drug Erbitux. Indianapolis-based Lilly said it will ... http://www.inboxrobot.com/news.php?fid=191831713 7 Oct 2008 05:26 GMT ... for approximately $6.5 billion in cash, which may put paid to the hopes of Bristol-Myers Squibb (BMS), after it had offered roughly $4.5 billion for the company July 31. This ... http://www.inboxrobot.com/news.php?fid=191827497 7 Oct 2008 04:56 GMT ... bid topped two previous offers from Bristol-Myers Squibb Co., which partnered with ImClone to develop ... blockbuster drug Erbitux. In July, New York-based Bristol offered $60 per share for the 83 ... http://www.inboxrobot.com/news.php?fid=191815703 7 Oct 2008 04:14 GMT ... bought by Eli Lilly for $70 a share after rejecting a sweetened offer from Bristol-Myers Squibb . The offer from Eli Lilly values ImClone, which makes the cancer drug Erbitux, ... http://www.inboxrobot.com/news.php?fid=191815670 7 Oct 2008 04:14 GMT ... bid topped two previous offers from Bristol-Myers Squibb Co., which partnered with ImClone to develop ... blockbuster drug Erbitux. In July, New York-based Bristol offered $60 per share for the 83 ... http://www.inboxrobot.com/news.php?fid=191814341 7 Oct 2008 04:08 GMT ... bought by Eli Lilly for $70 a share after rejecting a sweetened offer from Bristol-Myers Squibb . The offer from Eli Lilly values ImClone, which makes the cancer drug Erbitux, ... http://www.inboxrobot.com/news.php?fid=191812737 7 Oct 2008 04:00 GMT ... NEW YORK, Oct 6 (Reuters) - Bristol-Myers Squibb Co (BMY.N: ) on Monday said it exercised financial discipline by abandoning its efforts ... http://www.inboxrobot.com/news.php?fid=191809065 7 Oct 2008 03:34 GMT ... 132-year history in agreeing to buy cancer specialist ImClone. In doing so, he outbid Bristol-Myers Squibb Co (BMY.N: ), ImClone's partner on the cancer drug Erbitux. Viren Mehta, a principal ...